Stay updated with breaking news from Database Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Cabozantinib in combination with nivolumab and ipilimumab significantly reduced the risk of disease progression or death compared with the combination of nivolumab and ipilimumab - - Median progression-free
Research needed to examine role of nephrectomy in the era of modern immunotherapy combos
The evolution in systemic therapies for metastatic kidney cancer improved overall survival in a study of real-world patients.
The evolution in systemic therapies for metastatic kidney cancer improved overall survival in a study of real-world patients.
Real-world data confirm pazopanib to be safe and effective in patients with metastatic renal cell carcinoma.